Epitome Biosystems Expands Senior Management Team  
2/13/2007 1:26:11 PM

WALTHAM, Mass.--(BUSINESS WIRE)--Epitome Biosystems, a biotechnology company focused on innovative protein measurement systems, announced today the appointment of Jeffrey Radding, Ph.D., as Vice President, Research & Development. Dr. Radding joins the Company from Eli Lilly, where he led the Platform Biology Group in evaluating and implementing cell signaling approaches for drug discovery across multiple therapeutic areas.